Halozyme Therapeutics Inc (HALO)

Payables turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cost of revenue US$ in thousands 159,417 192,361 139,304 81,413 43,367
Payables US$ in thousands — — — — —
Payables turnover — — — — —

December 31, 2024 calculation

Payables turnover = Cost of revenue ÷ Payables
= $159,417K ÷ $—K
= —

Based on the provided data, it appears that Halozyme Therapeutics Inc has not reported any specific figures for its Payables turnover from December 31, 2020, to December 31, 2024. This lack of information makes it challenging to assess the company's efficiency in managing its accounts payable and the frequency with which it pays its suppliers over the specified period. Further details or additional financial data would be required to conduct a comprehensive analysis of the Payables turnover for Halozyme Therapeutics Inc.